Trademarkia Logo

Australia

AU$
KYNZETIX
Cancelled: Cancelled at the request of IB

Last updated on 12 Feb 2025

Owner Info

PTC Therapeutics, Inc.

100 Corporate Court

South Plainfield NJ 07080, UNITED STATES OF AMERICA

Serial Number

2320414 filed on 9 Nov 2022

Correspondent

Chetuan L. Shaffer

PTC Therapeutics, Inc.,,

100 Corporate Court,

UNITED STATES OF AMERICA

KYNZETIX

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of genetic diseases and disorders.

Mark Details


Serial Number

2320414

Registered On

9 Nov 2022

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

7 Jul 2022

Mark Type

US

Legal History


Show more

Status DateAction Taken
12th Feb 2025Status change to Voided
10th Aug 2023Amendment to International Registration Contact Requested
28th Feb 2023International Registration in Australia Protected correspondence sent
27th Feb 2023IP Right Registration Published
27th Feb 2023Status change to Registered/Protected
20th Dec 2022Application Accepted correspondence sent
19th Dec 2022IP Right has been Examined
19th Dec 2022IP Right Acceptance Published
19th Dec 2022Status change to Accepted
16th Dec 2022Awaiting examination